Aptevo Therapeutics Inc. buy me8
Summary
This prediction ended on 24.12.22 with a price of €2.15. Massive losses of -60.16% were the result for the BUY prediction by me8. This prediction was marked as speculative and is excluded from me8's performance statistics.Unfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Aptevo Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to me8 what are the pros and cons of Aptevo Therapeutics Inc. for the foreseeable future?
Pros
Cons
Comments by me8 for this prediction
In the thread Aptevo Therapeutics Inc diskutieren
In the thread Trading Aptevo Therapeutics Inc.